Canola oilseed- and Escherichia coli- derived hepatitis C virus (HCV) core proteins adjuvanted with oil bodies, induced robust Th1-oriented immune responses in immunized mice

APMIS. 2020 Nov;128(11):593-602. doi: 10.1111/apm.13074. Epub 2020 Sep 21.

Abstract

Induction of broad Th1 cellular immune responses and cytokines is crucial characteristics for vaccines against intracellular infections such as hepatitis C virus (HCV). Plants (especially oilseed tissues) and plant-immunomodulators (like oil bodies) offer cost-effective and scalable possibilities for the production of immunologically relevant and safe vaccine antigens and adjuvants, respectively. Herein, we provide data of the murine immunization by transgenic canola oilseed-derived HCV core protein (HCVcp) soluble extract (TSE) and Escherichia coli- derived rHCVcp in combination with Canola oil bodies (oil) compared to that of the Freund's (FA) adjuvant. Mice immunized by TSE+ oil developed both strong humeral (IgG) and Th1-biased cellular responses, manifested by high levels of IFN-γ and lower IgG1/IgG2a ratio and IL-4 secretion. Results of the intracellular cytokine staining indicated that TSE+ oil immunization in mice triggered both CD4+ and CD8+ T cells to release IFN-γ, while CD4+ cells were mostly triggered when FA was used. Analyses by qRT-PCR indicated that a combination of rHCVcp/TSE with oil body induced high levels of IL-10 cytokines compared to that of the FA adjuvant. These characteristics are important properties for the design of an HCV vaccine candidate and indicate the potential of Canola-derived antigen and oil bodies in addressing these concerns.

Keywords: Canola; HCV core protein; IFN-γ secreting lymphocytes; immune responses; oil bodies.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / chemistry
  • Animals
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / virology
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Female
  • Hepacivirus / drug effects*
  • Hepacivirus / immunology
  • Hepacivirus / pathogenicity
  • Hepatitis C, Chronic / immunology
  • Hepatitis C, Chronic / pathology
  • Hepatitis C, Chronic / prevention & control*
  • Hepatitis C, Chronic / virology
  • Immunity, Cellular / drug effects
  • Immunoglobulin G / biosynthesis
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / immunology
  • Mice
  • Mice, Inbred BALB C
  • Rapeseed Oil / administration & dosage
  • Rapeseed Oil / chemistry
  • Recombinant Proteins / administration & dosage*
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / immunology
  • Th1 Cells / drug effects*
  • Th1 Cells / immunology
  • Th1 Cells / virology
  • Viral Core Proteins / administration & dosage*
  • Viral Core Proteins / biosynthesis
  • Viral Core Proteins / immunology
  • Viral Hepatitis Vaccines / administration & dosage*
  • Viral Hepatitis Vaccines / biosynthesis

Substances

  • Adjuvants, Immunologic
  • IL10 protein, mouse
  • Immunoglobulin G
  • Rapeseed Oil
  • Recombinant Proteins
  • Viral Core Proteins
  • Viral Hepatitis Vaccines
  • Interleukin-10
  • Interferon-gamma